Publication

The following are some of the academic articles which have used MDV data.

Academic Articles

Total number of publications

789

Publication Icon

Search for Articles

The term "full-match search" refers to searching for items that contain all the words entered, while "partial-match search" refers to searching for items that contain even one of the words entered.

~

Search results: 18

Download Publication List

2025

TitleClinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer
AuthorsTakuya Nishina, Maki Tanioka, Kenji Takada, Takahiro Tsukioki, Yuko Takahashi, Tadahiko Shien & Shinichi Toyooka
PublishedBreast Cancer
Therapeutic AreaBreast cancer
TitleRisk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan
AuthorsAkinori Yuri, Sayuri Nakane, Yuki Miyano, Kana Yamada, Hiroshi Sugano, Erika Nakatsuji, Masahiko Aoki & Ayako Murayama
PublishedInternational Journal of Clinical Oncology
Therapeutic AreaBreast cancer
TitleReal-world treatment outcomes of abemaciclib in older patients with HR+, HER2- metastatic breast cancer in Japan
AuthorsTatsunori Shimoi, Yoshinori Tanizawa, Long Jin, Nobuyuki Sekine &Takahiro Nakayama
PublishedFuture Oncology
Therapeutic AreaBreast cancer
TitleInterstitial lung disease recurrence on chemotherapy rechallenge in breast cancer: a nationwide Japanese database
AuthorsSoichiro Nishijima, Keiko Sato, Tomohiro Onoue, Wataru Hashimoto & Mayumi Shikano
PublishedFuture Oncology
Therapeutic AreaBreast cancer
TitleTreatment patterns and clinical outcomes in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer treated with chemotherapy: a large-scale data analysis using the Japanese claims database
AuthorsTakayuki Kimura, Tomoko Takami, Yi Piao, Meng Wang & Shigehira Saji
PublishedBreast Cancer Research and Treatment
Therapeutic AreaBreast cancer

2024

TitleReal-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness
AuthorsTomoka Mamori, Maki Tanioka, Kenji Takada, Hirofumi Hamano, Takahiro Tsukioki, Yuko Takahashi, Tsuguo Iwatani, Tadahiko Shien & Shinichi Toyooka
PublishedBioDrugs
Therapeutic AreaBreast cancer
TitleReal-world data on patients with early breast cancer who were prescribed abemaciclib adjuvant therapy in Japan
AuthorsTatsunori Shimoi, Swathi Pathadka, Nobuyuki Sekine, Zhihong Cai, Yoshinori Tanizawa, Tsutomu Kawaguchi, Shigehira Saji & Toshinari Yamashita
PublishedFuture Oncology
Therapeutic AreaBreast cancer
TitleTreatment patterns and clinical outcomes in patients with metastatic triple-negative breast cancer: a large-scale data analysis using the Japanese claims database
AuthorsTakayuki Kimura, Tomoko Takami, Yi Piao, Ioanna Ntalla & Shigehira Saji
PublishedBreast Cancer Research and Treatment
Therapeutic AreaBreast cancer
TitleReal-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan
AuthorsAkihiko Shimomura, Yasuaki Sagara, Ryo Koto, Masakazu Fujiwara, Yuka Kanemura, Hiroshi Kitagawa & Shigehira Saji
PublishedBreast Cancer
Therapeutic AreaBreast cancer
TitleOsteoporotic fracture risk in women with breast cancer treated with aromatase inhibitors: a health insurance claims database study in Japan
AuthorsTetsuya Taguchi, Hisashi Matsushima, Sho Kodama, Naoki Okubo, Tetsuo Ito, Maja Ludwikowska, Seiji Fukumoto & Toshio Matsumoto
PublishedExpert Opinion on Pharmacotherapy
Therapeutic AreaBreast cancer
TitleTreatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan
AuthorsHitomi Sanno, Kazuko Taniguchi, Yuya Yoshimoto & Shigehira Saji
PublishedFuture Oncology
Therapeutic AreaBreast cancer

2023

TitleOpioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study
AuthorsManami Yoshida, Kosuke Iwasaki, Mitsunori Miyashita, Toshiaki Saeki, Yasuhide Morioka, Shinzo Hiroi & Eiko Shimizu
PublishedSupportive Care in Cancer
Therapeutic AreaBreast cancer
TitleReal-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer
AuthorsNobuhiro Shibata, Tetsuhiro Yoshinami, Kentaro Tamaki, Tomoyuki Nukada & Shinji Ohno
PublishedBreast Cancer Research and Treatment
Therapeutic AreaBreast cancer
TitleReal-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
AuthorsMasataka Sawaki, Yasuaki Muramatsu, Kanae Togo, Hiroji Iwata
PublishedThe Breast
Therapeutic AreaBreast cancer
TitleIncidence of interstitial lung disease in patients with breast cancer: a nationwide database study in Japan
AuthorsSoichiro Nishijima, Keiko Sato, Tomohiro Onoue, Wataru Hashimoto & Mayumi Shikano
PublishedFuture Oncology
Therapeutic AreaBreast cancer

2022

TitleReal-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan
AuthorsMasataka Sawaki, Yasuaki Muramatsu, Kanae Togo, Thomas Laurent & Hiroji Iwata
PublishedFUTURE ONCOLOGY
Therapeutic AreaBreast cancer
TitlePatient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database
AuthorsMasaaki Kawai, Masahiro Takada, Takahiro Nakayama, Norikazu Masuda, Hirokazu Shiheido, Zhihong Cai, Yu-Jing Huang, Tsutomu Kawaguchi & Yoshinori Tanizawa
PublishedBreast Cancer Research and Treatment
Therapeutic AreaBreast cancer

2021

TitleCharacteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan
AuthorsYucherng Chen, Satoshi Noma, Yoshio Taguchi, Masashi Takahashi, Junji Tsurutani, Shiho Mori, Sachi Sakaguchi, Hiroya Asou & Keisuke Tomii
PublishedBreast Cancer
Therapeutic AreaBreast cancer

About Japanese Healthcare System

What you need to know about the healthcare system in Japan before using the data.

SERVICE

In addition to various web tools that allow you to easily conduct surveys via a browser using our medical database, we offer data provision services categorized into four types to meet your needs and challenges: "Analysis reports" "Datasets," "All Therapeutic Areas Data Provision Service," and "Specific Therapeutic Areas Data Provision Service.

page top